Michael H. Tatham

6.1k total citations · 2 hit papers
53 papers, 4.9k citations indexed

About

Michael H. Tatham is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Michael H. Tatham has authored 53 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 22 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Michael H. Tatham's work include Ubiquitin and proteasome pathways (44 papers), Peptidase Inhibition and Analysis (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Michael H. Tatham is often cited by papers focused on Ubiquitin and proteasome pathways (44 papers), Peptidase Inhibition and Analysis (12 papers) and Glycosylation and Glycoproteins Research (10 papers). Michael H. Tatham collaborates with scholars based in United Kingdom, United States and Germany. Michael H. Tatham's co-authors include Ronald T. Hay, Ellis Jaffray, Anna Plechanovová, James H. Naismith, Ivan Matić, Linnan Shen, Neil Hattersley, Matthias Mann, Catherine H. Botting and O. Anthony Vaughan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael H. Tatham

53 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9

2001 689 citations Michael H. Tatham, Ellis Jaffray et al. profile →
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation

2008 678 citations Michael H. Tatham, Marie‐Claude Geoffroy et al. Nature Cell Biology profile →

Peers

Countries citing papers authored by Michael H. Tatham

Since Specialization

Citations

This map shows the geographic impact of Michael H. Tatham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Tatham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Tatham more than expected).

Fields of papers citing papers by Michael H. Tatham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael H. Tatham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Tatham. The network helps show where Michael H. Tatham may publish in the future.

Co-authorship network of co-authors of Michael H. Tatham

This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Tatham. A scholar is included among the top collaborators of Michael H. Tatham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Tatham. Michael H. Tatham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways 2025 ·The Journal of Cell Biology ·Ellis Jaffray, Michael H. Tatham, Barbara Mojsa, Anna Plechanovová, Alejandro Rojas‐Fernández, (unknown), Niels Mailand, Adel F.M. Ibrahim, Graeme Ball, Iain M. Porter, Ronald T. Hay	1
2	Mechanism of degrader-targeted protein ubiquitinability 2024 ·Science Advances ·(unknown), Mark A. Nakasone, (unknown), Conner Craigon, Gajanan Sathe, Michael H. Tatham, Nikolai Makukhin, Ronald T. Hay, Alessio Ciulli	25
3	Concerted SUMO-targeted ubiquitin ligase activities of TOPORS and RNF4 are essential for stress management and cell proliferation 2024 ·Nature Structural & Molecular Biology ·(unknown), Leena Ackermann, Saskia Hoffmann, (unknown), Ivo A. Hendriks, Charu Jain, (unknown), Michael H. Tatham, Gian‐Luca McLelland, Ronald T. Hay, Michael L. Nielsen, Thijn R. Brummelkamp, Peter Haahr, Niels Mailand	15
4	The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA 2023 ·The Journal of Cell Biology ·Ellis Jaffray, Michael H. Tatham, Barbara Mojsa, (unknown), Alejandro Rojas‐Fernández, Yili Yin, Graeme Ball, Ronald T. Hay	11
5	SUMO protease SENP6 protects the nucleus from hyperSUMOylation-induced laminopathy-like alterations 2023 ·Cell Reports ·(unknown), Michael H. Tatham, Barbara Mojsa, (unknown), Alejandro Rojas‐Fernández, Adel F.M. Ibrahim, Ronald T. Hay	5
6	Lysine deserts prevent adventitious ubiquitylation of ubiquitin-proteasome components 2023 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), (unknown), Michael H. Tatham, Matteo Cagiada, Kresten Lindorff‐Larsen, Wouter Boomsma, Kay Hofmann, Rasmus Hartmann‐Petersen	5
7	Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1 2023 ·PLoS Pathogens ·Carlos F. de la Cruz-Herrera, Michael H. Tatham, (unknown), Kathy Shire, Edyta Marcon, Jack Greenblatt, Ronald T. Hay, Lori Frappier	10
8	SUMOylation stabilizes sister kinetochore biorientation to allow timely anaphase 2021 ·The Journal of Cell Biology ·Xue Bessie Su, Menglu Wang, (unknown), Olga O. Nerusheva, Dean Clift, Christos Spanos, David A. Kelly, Michael H. Tatham, (unknown), (unknown), Juri Rappsilber, A. Arockia Jeyaprakash, Zuzana Štorchová, Ronald T. Hay, Adèle L. Marston	11
9	Antibody RING-Mediated Destruction of Endogenous Proteins 2020 ·Molecular Cell ·Adel F.M. Ibrahim, Linnan Shen, Michael H. Tatham, David Dickerson, Alan R. Prescott, (unknown), Dimitris P. Xirodimas, Ronald T. Hay	46
10	The SUMOylation pathway suppresses arbovirus replication in Aedes aegypti cells 2020 ·PLoS Pathogens ·(unknown), (unknown), Michael H. Tatham, Steven McFarlane, Peter Mertens, Emilie Pondeville, Chris Boutell	15
11	Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and β-Catenin–Independent Targets by Proteomics 2019 ·Molecular Cancer Research ·(unknown), João A. Paulo, Michael H. Tatham, (unknown), Alejandro Rojas‐Fernández, Nicolas Loyer, Ian P. Newton, Jens Januschke, Kevin M. Haigis, Inke Näthke	5
12	The S phase checkpoint promotes the Smc5/6 complex dependent SUMOylation of Pol2, the catalytic subunit of DNA polymerase ε 2019 ·PLoS Genetics ·Alicja Winczura, (unknown), Michael H. Tatham, Ronald T. Hay, Giacomo De Piccoli	14
13	Multiomics Analyses of HNF4α Protein Domain Function during Human Pluripotent Stem Cell Differentiation 2019 ·iScience ·Yu Wang, Michael H. Tatham, Wolfgang Schmidt‐Heck, (unknown), Karamjit Singh Dolt, Jose Meseguer-Ripolles, Baltasar Lucendo‐Villarin, Tilo Kunath, Timothy R. Rudd, Andrew J. H. Smith, Jan G. Hengstler, Patrício Godoy, Ronald T. Hay, David C. Hay	11
14	Global Reprogramming of Host SUMOylation during Influenza Virus Infection 2015 ·Cell Reports ·Patricia Domingues, Filip Gołębiowski, Michael H. Tatham, António M. Lopes, Aislynn Taggart, Ronald T. Hay, Benjamin G. Hale	77
15	SUMO Chain-Induced Dimerization Activates RNF4 2014 ·Molecular Cell ·Alejandro Rojas‐Fernández, Anna Plechanovová, Neil Hattersley, Ellis Jaffray, Michael H. Tatham, Ronald T. Hay	63
16	High-stringency tandem affinity purification of proteins conjugated to ubiquitin-like moieties 2010 ·Nature Protocols ·Filip Gołębiowski, Michael H. Tatham, Akihiro Nakamura, Ronald T. Hay	15
17	Detection of protein SUMOylation in vivo 2009 ·Nature Protocols ·Michael H. Tatham, Manuel S. Rodríguez, Dimitris P. Xirodimas, Ronald T. Hay	140
18	RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation breakdown → 2008 ·Nature Cell Biology ·Michael H. Tatham, Marie‐Claude Geoffroy, Linnan Shen, Anna Plechanovová, Neil Hattersley, Ellis Jaffray, Jorma J. Palvimo, Ronald T. Hay	678
19	FRET-Based In Vitro Assays for the Analysis of SUMO Protease Activities 2008 ·Methods in molecular biology ·Michael H. Tatham, Ronald T. Hay	14
20	SUMO and transcriptional regulation 2004 ·Seminars in Cell and Developmental Biology ·(unknown), Michael H. Tatham, Ronald T. Hay	144

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact